Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Tang-Du Hospital | OTHER |
| Kunming Medical University | OTHER |
| First Affiliated Hospital of Fujian Medical University | OTHER |
| Nanjing PLA General Hospital |
Not provided
Not provided
Not provided
Not provided
In the stage of randomized controlled study, our purpose is to obtain the Intraoperative anticoagulation program supported by evidence-based medicine.
This study is divided into anticoagulation program in cerebral aneurysm with hybrid operation and anticoagulation program in cerebral arteriovenous malformations with hybrid operation two parts, and each part divide into two stage, on the stage of registration study. This study is a multi-center, single-blind, prospective cohort study. Record the patient's intraoperative activated coagulation time Changes in detail, to observe the effect of activated coagulation time maintenance level on hemorrhage event rate of Intraoperative and postoperative 48 hours, purpose to find out the safety range of activated coagulation time level in cerebral aneurysm and arteriovenous malformations with hybrid operation. On the stage of randomized controlled study. This study is a multicenter, single-blind, prospective, randomized controlled study. Patients is divided into intraoperative standard dose group of Heparin Sodium and low dose group of Heparin Sodium randomly. To observe the effect of different anticoagulation regimens on activated coagulation time safety coverage rate during surgery, and finally develop a scientific and effective intraoperative anticoagulant therapy program.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard dose group of Heparin Sodium | Experimental | First infused with 5000 IU of Heparin Sodium, then continuous infusion at a rate of 18 IU / kg.h during the hybrid operation. |
|
| Low dose group of Heparin Sodium | Active Comparator | infusion Heparin Sodium at a rate of 18 IU / kg.h during the hybrid operation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Heparin Sodium | Drug | Infused with 5000 IU of Heparin Sodium |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in activated coagulation time safety coverage rate from the beginning of surgery to 48 hours after surgery | Activated coagulation time average value falls in the safety coverage rate from the beginning of surgery to 48 hours after surgery. | From the beginning of surgery to 48 hours after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in hemorrhage event rate from the beginning of surgery to 48 hours after surgery | Hemorrhage event include intracranial hemorrhage caused by non-surgical reasons, as well as other organs or parts of the massive bleeding or small bleeding, Including subperitoneal hemorrhage, intraocular hemorrhage, gross hematuria, epistaxis time prolonged or repeated, gastrointestinal bleeding, hemoptysis, subconjunctival hemorrhage, hematoma greater than 5cm, bleeding difficult to control the and so on. |
Not provided
Inclusion Criteria:
1.All patients undergoing hybird surgery.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yong Cao, Doctor | Contact | 010-67096510 | caoyong6@hotmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing Tiantan Hospital, Capital Medical University | Recruiting | Beijing | Beijing Municipality | 100050 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002532 | Intracranial Aneurysm |
| D001165 | Arteriovenous Malformations |
| ID | Term |
|---|---|
| D020765 | Intracranial Arterial Diseases |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006493 | Heparin |
| ID | Term |
|---|---|
| D006025 | Glycosaminoglycans |
| D011134 | Polysaccharides |
| D002241 | Carbohydrates |
Not provided
Not provided
| OTHER |
| Fujian Medical University Union Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
| Heparin Sodium |
| Drug |
Infusion Heparin Sodium at a rate of 18 IU / kg.h |
|
| From the beginning of surgery to 48 hours after surgery |
| Changes in ischemia event rate from the beginning of surgery to 48 hours after surgery | Ischemia event include Cerebral infarction and transient ischemic attack. | From the beginning of surgery to 48 hours after surgery |
| Intraoperative blood loss | All the blood lost during the surgery should be collected and measured. | From the beginning of surgery to 48 hours after surgery |
| D009422 | Nervous System Diseases |
| D000783 | Aneurysm |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D054079 | Vascular Malformations |
| D018376 | Cardiovascular Abnormalities |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |